Citations (44)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Ghulam Hussain, Haseeb Anwar, Azhar Rasul, Ali Imran, Muhammad Qasim, Shamaila Zafar, Muhammad Imran, Syed Kashif Shahid Kamran, Nimra Aziz, Aroona Razzaq, Waseem Ahmad, Asghar Shabbir, Javed Iqbal, Shahid Mahmood Baig, Muhammad Ali, Jose-Luis Gonzalez de Aguilar, Tao Sun, Atif Muhammad & Arshadm Muhammad Umair. (2020) Lipids as biomarkers of brain disorders. Critical Reviews in Food Science and Nutrition 60:3, pages 351-374.
Read now
Read now
Articles from other publishers (43)
Yudong Xu, Huihui Hong, Xiqin Lin, Tong Tong, Jingjing Zhang, Haotian He, Lingling Yang, Gaofeng Mao, Rongrong Hao, Ping Deng, Zhengping Yu, Huifeng Pi, Yong Cheng & Zhou Zhou. (2023) Chronic cadmium exposure induces Parkinson-like syndrome by eliciting sphingolipid disturbance and neuroinflammation in the midbrain of C57BL/6J mice. Environmental Pollution 337, pages 122606.
Crossref
Crossref
Hangzhen Li, Fancai Zeng, Cancan Huang, Qiqi Pu, Elizabeth Rosalind Thomas, Yan Chen & Xiang Li. (2023) The potential role of glucose metabolism, lipid metabolism, and amino acid metabolism in the treatment of Parkinson's disease. CNS Neuroscience & Therapeutics.
Crossref
Crossref
Sara Mohammadi, Mirmohsen Sharifi Bonab, Mahdyieh Hamed Behzad & Bahram Pourghassem Gargari. (2023) Effects of omega-3 polyunsaturated fatty acids on the levels of pro- and anti-inflammatory cytokines and lipid profile in patients with Parkinson's disease. Nutrition Clinique et Métabolisme.
Crossref
Crossref
Mohammed Alrouji, Hayder M. Al-Kuraishy, Abdul-karim Abd Ali Al-Mahammadawy, Ali I. Al-Gareeb, Hebatallah M. Saad & Gaber El-Saber Batiha. (2023) The potential role of cholesterol in Parkinson’s disease neuropathology: perpetrator or victim. Neurological Sciences.
Crossref
Crossref
Elisa Menozzi, Marco Toffoli & Anthony H.V. Schapira. (2023) Targeting the GBA1 pathway to slow Parkinson disease: Insights into clinical aspects, pathogenic mechanisms and new therapeutic avenues. Pharmacology & Therapeutics 246, pages 108419.
Crossref
Crossref
Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, Athanasios Alexiou, Marios Papadakis, Abdulrahman A. Alsayegh, Najlaa Hamed Almohmadi, Hebatallah M. Saad & Gaber El‐Saber Batiha. (2023) Pros and cons for statins use and risk of Parkinson's disease: An updated perspective. Pharmacology Research & Perspectives 11:2.
Crossref
Crossref
Yaiza Corral Nieto, Sokhna M. S. Yakhine-Diop, Paula Moreno-Cruz, Laura Manrique García, Amanda Gabrielly Pereira, José A. Morales-García, Mireia Niso-Santano, Rosa A. González-Polo, Elisabet Uribe-Carretero, Sylvère Durand, Maria Chiara Maiuri, Marta Paredes-Barquero, Eva Alegre-Cortés, Saray Canales-Cortés, Adolfo López de Munain, Jordi Pérez-Tur, Ana Pérez-Castillo, Guido Kroemer, José M. Fuentes & José M. Bravo-San Pedro. (2023) Changes in Liver Lipidomic Profile in G2019S-LRRK2 Mouse Model of Parkinson’s Disease. Cells 12:5, pages 806.
Crossref
Crossref
Michael Sloth Trabjerg, Dennis Christian Andersen, Pam Huntjens, Kasper Mørk, Nikolaj Warming, Ulla Bismark Kullab, Marie-Louise Nibelius Skjønnemand, Michal Krystian Oklinski, Kirsten Egelund Oklinski, Luise Bolther, Lona J. Kroese, Colin E. J. Pritchard, Ivo J. Huijbers, Angelique Corthals, Mads Toft Søndergaard, Henrik Bech Kjeldal, Cecilie Fjord Morre Pedersen & John Dirk Vestergaard Nieland. (2023) Inhibition of carnitine palmitoyl-transferase 1 is a potential target in a mouse model of Parkinson’s disease. npj Parkinson's Disease 9:1.
Crossref
Crossref
Weiwei Wang, Ze Li, Xiaona Zhang, Jie Zhang & Shaoguo Ru. (2022) Bisphenol S Impairs Behaviors through Disturbing Endoplasmic Reticulum Function and Reducing Lipid Levels in the Brain of Zebrafish. Environmental Science & Technology 57:1, pages 582-594.
Crossref
Crossref
Gang Wu, Zhengli Jiang, Yaling Pu, Shiyong Chen, Tingling Wang, Yajing Wang, Xiaoping Xu, Shanshan Wang, Minya Jin, Yangyang Yao, Yang Liu, Shaofa Ke & Suzhi Liu. (2022) Serum short-chain fatty acids and its correlation with motor and non-motor symptoms in Parkinson’s disease patients. BMC Neurology 22:1.
Crossref
Crossref
Mahmoud A. Alomari, Hanan Khalil, Omar F. Khabour & Karem H. Alzoubi. (2022) Lipid profile in Parkinson's disease: The potential role of brain-derived neurotrophic factor. Life Sciences 311, pages 121144.
Crossref
Crossref
Jasmin Galper, Nicholas J Dean, Russell Pickford, Simon J G Lewis, Glenda M Halliday, Woojin S Kim & Nicolas Dzamko. (2022) Lipid pathway dysfunction is prevalent in patients with Parkinson’s disease. Brain 145:10, pages 3472-3487.
Crossref
Crossref
Yangfan Zhao & Sarah A. Gagliano Taliun. (2022) Lipid-lowering drug targets and Parkinson's disease: A sex-specific Mendelian randomization study. Frontiers in Neurology 13.
Crossref
Crossref
Meimei Zhang, Huimin Chen, Genliang Liu, Xuemei Wang, Zhan Wang, Tao Feng & Yumei Zhang. (2022) Lower serum triglyceride levels linked to more severe motor performance in Parkinson’s disease. Neurological Sciences 43:9, pages 5343-5353.
Crossref
Crossref
Dhivya Venkatesan, Mahalaxmi Iyer, Robert Wilson S.Arul Narayanasamy, Siva Kamalakannan, Abilash Valsala Gopalakrishnan & Balachandar Vellingiri. (2022) Genotypic-Phenotypic Analysis, Metabolic Profiling and Clinical Correlations in Parkinson’s Disease Patients from Tamil Nadu Population, India. Journal of Molecular Neuroscience 72:8, pages 1724-1737.
Crossref
Crossref
Xue Hong, Wenting Guo & Shanshan Li. (2022) Lower Blood Lipid Level Is Associated with the Occurrence of Parkinson’s Disease: A Meta-Analysis and Systematic Review. International Journal of Clinical Practice 2022, pages 1-10.
Crossref
Crossref
François-Xavier Lejeune, Farid Ichou, Etienne Camenen, Benoit Colsch, Florence Mauger, Caroline Peltier, Ivan Moszer, Emmanuel Gilson, Morgane Pierre-Jean, Edith Le Floch, Victor Sabarly, Arthur Tenenhaus, Jean-François Deleuze, Claire Ewenczyk, Marie Vidailhet & Fanny Mochel. (2022) A Multimodal Omics Exploration of the Motor and Non-Motor Symptoms of Parkinson’s Disease. International Journal of Translational Medicine 2:1, pages 97-112.
Crossref
Crossref
Shelby Loraine Hatton & Manoj Kumar Pandey. (2022) Fat and Protein Combat Triggers Immunological Weapons of Innate and Adaptive Immune Systems to Launch Neuroinflammation in Parkinson’s Disease. International Journal of Molecular Sciences 23:3, pages 1089.
Crossref
Crossref
Senni Bunga, Alan Carne & Alaa El-Din A. Bekhit. 2022. Fish Roe. Fish Roe
41
92
.
Zhu Liu, Qingli Fan, Shizheng Wu, Yaqi Wan & Yancheng Lei. (2021) Compared with the monocyte to high-density lipoprotein ratio (MHR) and the neutrophil to lymphocyte ratio (NLR), the neutrophil to high-density lipoprotein ratio (NHR) is more valuable for assessing the inflammatory process in Parkinson’s disease. Lipids in Health and Disease 20:1.
Crossref
Crossref
Ji Hyoun Kim, In Ah Choi, Aryun Kim & Gilwon Kang. (2021) Clinical Association between Gout and Parkinson’s Disease: A Nationwide Population-Based Cohort Study in Korea. Medicina 57:12, pages 1292.
Crossref
Crossref
Mei-Xue Dong, You-Dong Wei & Ling Hu. (2021) The disturbance of lipid metabolism is correlated with neuropsychiatric symptoms in patients with Parkinson’s disease. Chemistry and Physics of Lipids 239, pages 105112.
Crossref
Crossref
Keran Wang, Zhehui Luo, Chenxi Li, Xuemei Huang, Eric J. Shiroma, Eleanor M. Simonsick & Honglei Chen. (2021) Blood Cholesterol Decreases as Parkinson’s Disease Develops and Progresses. Journal of Parkinson's Disease 11:3, pages 1177-1186.
Crossref
Crossref
Daniel Macías-García, María Teresa Periñán, Laura Muñoz-Delgado, María Valle Jimenez-Jaraba, Miguel Ángel Labrador-Espinosa, Silvia Jesús, Dolores Buiza-Rueda, Carlota Méndez-Del Barrio, Astrid Adarmes-Gómez, Pilar Gómez-Garre & Pablo Mir. (2021) Serum lipid profile among sporadic and familial forms of Parkinson’s disease. npj Parkinson's Disease 7:1.
Crossref
Crossref
Tanvi Dayanand Pingale & Girdhari Lal Gupta. (2021) Novel therapeutic approaches for Parkinson’s disease by targeting brain cholesterol homeostasis. Journal of Pharmacy and Pharmacology 73:7, pages 862-873.
Crossref
Crossref
Patricia García‐Sanz, Johannes Aerts & Rosario Moratalla. (2020)
The Role of Cholesterol in
α‐Synuclein
and Lewy Body Pathology in
GBA1
Parkinson's Disease
. Movement Disorders 36:5, pages 1070-1085.
Crossref
Crossref
Yi Lu, Xiaojie Jin & Peng Zhao. (2020) Serum lipids and the pathogenesis of Parkinson's disease: A systematic review and meta‐analysis. International Journal of Clinical Practice 75:4.
Crossref
Crossref
Giovanni Mario Pes, Yong-Moon Park & Gian Pietro Sechi. (2021) Cholesterol Trafficking in the Brain. Neurology 96:10, pages 465-466.
Crossref
Crossref
Joo-Hyun ParkChung-woo LeeMyung Ji NamHyunjin KimDo-Young KwonJi Won YooKyu Na LeeKyungdo HanJin-Hyung JungYong-Gyu ParkDo-Hoon Kim. (2021) Association of High-Density Lipoprotein Cholesterol Variability and the Risk of Developing Parkinson Disease. Neurology 96:10.
Crossref
Crossref
Helena Xicoy, Cornelius JHM Klemann, Ward De Witte, Marijn B Martens, Gerard JM Martens & Geert Poelmans. (2021) Shared genetic etiology between Parkinson’s disease and blood levels of specific lipids. npj Parkinson's Disease 7:1.
Crossref
Crossref
Xiaoxue Fu, Yu Wang, Xiaofeng He, Hongyu Li, Hong Liu & Xiangyang Zhang. (2020) A systematic review and meta-analysis of serum cholesterol and triglyceride levels in patients with Parkinson’s disease. Lipids in Health and Disease 19:1.
Crossref
Crossref
Joanna Samborska-Ćwik, Stanisław Szlufik, Andrzej Friedman, Tomasz Mandat, Andrzej Przybyszewski & Dariusz Koziorowski. (2020) Influence of Bilateral Subthalamic Nucleus Deep Brain Stimulation on the Lipid Profile in Patients With Parkinson's Disease. Frontiers in Neurology 11.
Crossref
Crossref
Michael Sloth Trabjerg, Anne Skøttrup Mørkholt, Jacek Lichota, Michal Krystian Egelund Oklinski, Dennis Christian Andersen, Katrine Jønsson, Kasper Mørk, Marie-Louise Nibelius Skjønnemand, Lona John Kroese, Colin Eliot Jason Pritchard, Ivo Johan Huijbers, Parisa Gazerani, Angelique Corthals & John Dirk Vestergaard Nieland. (2020) Dysregulation of metabolic pathways by carnitine palmitoyl-transferase 1 plays a key role in central nervous system disorders: experimental evidence based on animal models. Scientific Reports 10:1.
Crossref
Crossref
Sokhna M.S. Yakhine-Diop, José A. Morales-García, Mireia Niso-Santano, Rosa A. González-Polo, Elisabet Uribe-Carretero, Guadalupe Martinez-Chacon, Sylvere Durand, Maria Chiara Maiuri, Ana Aiastui, Miren Zulaica, Javier Ruíz-Martínez, Adolfo López de Munain, Jordi Pérez-Tur, Ana Pérez-Castillo, Guido Kroemer, José M. Bravo-San Pedro & José M. Fuentes. (2020) Metabolic alterations in plasma from patients with familial and idiopathic Parkinson’s disease. Aging 12:17, pages 16690-16708.
Crossref
Crossref
Doo Sin Jo, Na Yeon Park & Dong-Hyung Cho. (2020) Peroxisome quality control and dysregulated lipid metabolism in neurodegenerative diseases. Experimental & Molecular Medicine 52:9, pages 1486-1495.
Crossref
Crossref
Wanlin Yang, Zihan Chang, Rongfang Que, Guomei Weng, Bin Deng, Ting Wang, Zifeng Huang, Fen Xie, Xiaobo Wei, Qin Yang, Mengyan Li, Kefu Ma, Fengli Zhou, Beisha Tang, Vincent C. T. Mok, Shuzhen Zhu & Qing Wang. (2020) Contra-Directional Expression of Plasma Superoxide Dismutase with Lipoprotein Cholesterol and High-Sensitivity C-reactive Protein as Important Markers of Parkinson’s Disease Severity. Frontiers in Aging Neuroscience 12.
Crossref
Crossref
Liubov S. Kalinichenko, Erich Gulbins, Johannes Kornhuber & Christian P. Müller. 2020. Handbook of the Behavioral Neurobiology of Serotonin. Handbook of the Behavioral Neurobiology of Serotonin
289
308
.
Fauze Camargo Maluf, David Feder & Alzira Alves de Siqueira Carvalho. (2019) Analysis of the Relationship between Type II Diabetes Mellitus and Parkinson’s Disease: A Systematic Review. Parkinson's Disease 2019, pages 1-14.
Crossref
Crossref
Uram Jin, Soo Jin Park & Sang Myun Park. (2019) Cholesterol Metabolism in the Brain and Its Association with Parkinson’s Disease. Experimental Neurobiology 28:5, pages 554-567.
Crossref
Crossref
Doo Sin Jo & Dong-Hyung Cho. (2019) Peroxisomal dysfunction in neurodegenerative diseases. Archives of Pharmacal Research 42:5, pages 393-406.
Crossref
Crossref
Helena Xicoy, Bé Wieringa & Gerard J. M. Martens. (2019) The Role of Lipids in Parkinson’s Disease. Cells 8:1, pages 27.
Crossref
Crossref
Violetta Rozani, Tanya Gurevich, Nir Giladi, Baruch El-Ad, Judith Tsamir, Beatriz Hemo & Chava Peretz. (2018) Higher serum cholesterol and decreased Parkinson's disease risk: A statin-free cohort study. Movement Disorders 33:8, pages 1298-1305.
Crossref
Crossref
Farzaneh Rahmani & Mohammad Hadi Aarabi. (2017) Does apolipoprotein A1 predict microstructural changes in subgenual cingulum in early Parkinson?. Journal of Neurology 264:4, pages 684-693.
Crossref
Crossref